FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’ – CNN

by

  1. FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’ CNN
  2. FDA approves Merck’s drug for rare, deadly lung condition CNBC
  3. FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1) Merck
  4. FDA Approves Sotatercept, First-in-Class Treatment for Adults With PAH AJMC.com Managed Markets Network
  5. Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives The Wall Street Journal

Read original article here

Leave a Comment